Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis

Nephrology

Volumn 12, Issue 3, 2007, Pages 224-233

  Van Eps, Carolyn L ^a   Jeffries, Janine K ^a   Anderson, John A ^a   Bergin, Patrick T ^a   Johnson, David W ^a   Campbell, Scott B ^a   Carpenter, Sally M ^a   Isbel, Nicole M ^a   Mudge, David W ^a   Hawley, Carmel M ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Bone histomorphology; Bone mineral density; Bone mineral metabolism; Hyperparathyroidism; Nocturnal haemodialysis; Vascular calcification

Indexed keywords

ALKALINE PHOSPHATASE; BICARBONATE; CALCIUM PHOSPHATE; PARATHYROID HORMONE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BICARBONATE BLOOD LEVEL; BLOOD VESSEL CALCIFICATION; BONE DENSITY; BONE MINERALIZATION; BONE TURNOVER; CALCIFICATION; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS PATIENT; HOME DIALYSIS; HUMAN; MALE; MORPHOMETRICS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS;

ABSORPTIOMETRY, PHOTON; BONE AND BONES; BONE DENSITY; CALCINOSIS; CALCIUM; ELECTROLYTES; EXTREMITIES; FEMALE; HEMODIALYSIS, HOME; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PERIPHERAL VASCULAR DISEASES; PHOSPHATES; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY;

EID: 34248180551     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2006.00712.x     Document Type: Article

References (38)

1. Slinin Y, Foley R, Collins A. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in haemodialysis patients: The USRDS waves 1, 3, and 4 study. J. Am. Soc. Nephrol. 2005 16 : 1788 93.
2. Block G, Klassen P, Lazarus J, Ofsthun N, Lowrie E, Chertow G. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J. Am. Soc. Nephrol. 2004 15 : 2208 18.
3. Young E, Takashi Akiba M, Albert J et al. Magnitude and impact of abnormal mineral metabolism in haemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS). Am. J. Kidney Dis. 2004 44 (Suppl. 2 S34 8.
4. Musci I, Hercz G, Uldall R, Ouwendyk M, Francoeur F, Pierratos A. Control of serum phosphate without any phosphate binders in patients treated with nocturnal haemodialysis. Kidney Int. 1998 53 : 1399 404.
5. Pierratos A. Daily nocturnal home hemodialysis. Kidney Int. 2004 65 : 1975 86.
6. Pierratos A. Nocturnal home haemodialysis: An update on a 5-year experience. Nephrol. Dial. Transplant. 1999 14 : 2835 40.
7. Al-Hejaili F, Kortas C, Leitch R et al. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. J. Am. Soc. Nephrol. 2003 14 : 2322 8.
8. Lindsay R, Alhejali F, Nesrallah G et al. Calcium and phosphate balance with quotidian hemodialysis. Am. J. Kidney Dis. 2003 42 (Suppl. 1 S24 9.
9. Kroeker A, Clarke W, Heidenheim A. An operating cost comparison between conventional and home quotidian hemodialysis. Am. J. Kidney Dis. 2003 42 (Suppl. 1 S49 55.
10. Schulman G. Daily hemodialysis: The time has come. Am. J. Kidney Dis. 2005 45 : 798 803.
11. Mahadevan K, Agar J, Somerville C, Simmonds R, Boddington J, Waldron C. Comparison of access site infection in nocturnal vs conventional daily hemodialysis. Nephrology 2004 9 (Suppl. 1 A13.
12. Suri R, Nesrallah G, Mainra R et al. Daily hemodialysis: A systematic review. Clin. J. Am. Soc. Nephrol. 2006 1 : 33 42.
13. Toma S, Takahiro S, Hiroyoshi F et al. A timesaving method to create a fixed puncture route for the buttonhole technique. Nephrol. Dial. Transplant. 2003 18 : 2118 21.
14. Kronenberg F, Mundle M, Langle M, Neyer U. Prevalence and progression of peripheral arterial calcifications in patients with ESRD. Am. J. Kidney Dis. 2003 41 : 140 48.
15. Moe S, Drueke T, Cunningham J et al. Definition, evaluation, and classification of renal osteodystrophy: A position statement from kidney diseases: Improving global outcomes (KDIGO). Kidney Int. 2006 69 : 1945 53.
16. Hawley C, Elder G. Caring for Australasians with Renal Impairment Guidelines: Biochemical and Haematological Targets: Sections Entitled, Calcium, Phosphate, Calcium*Phosphate Product and Parathyroid Hormone, 2006. [Cited 18 September 2006.] Available from URL: http://www.cari.org.au
17. Laurent G, Charra B. The results of an 8 h thrice weekly haemodialysis schedule. Nephrol. Dial. Transplant. 1998 13 (Suppl. 6 125 31.
18. Jean G, Chazot C, Charra B. Biological evolution of renal osteodystrophy after decreasing dialysate calcium from 1.75 to 1.6 mmol./1. Clin. Nephrol. 2002 57 : 91 2.
19. Agar J, Madadevan K, Pelicano R, Kerr P. Comparing two nocturnal haemodialysis programs with different frequencies. J. Am. Soc. Nephrol. 2004 14 : 403A, and slide presentation of this abstract.
20. Buoncristiani U. Fifteen years of clinical experience with daily haemodialysis. Nephrol. Dial. Transplant. 1998 13 : 148 51.
21. Ayus J, Mizani M, Achinger S, Thadhani R, Go A, Lee S. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: A prospective, controlled study. J. Am. Soc. Nephrol. 2005 16 : 2778 88.
22. Tomson CR. Cardiovascular disease in chronic renal failure. In : Johnson R, Feehally J (eds). Comprehensive Clinical Nephrology, 2nd edn. Xxxx : Elselvier Limited, 2003 887 904.
23. Toussaint N, Boddington J, Simmonds R, Waldron C, Sommerville C, Agar J. Calcium phosphate metabolism and bone mineral density with nocturnal hemodialysis. Hemodial. Int. 2006 10 : 280 86.
24. Kyriazis J, Stamatiadis D, Mamouna A. Intradialytic and Interdialytic effects of treatment with 1.25 and 1.75 mmol/L of calcium dialysate on arterial compliance in patients on hemodialysis. Am. J. Kidney Dis. 2000 35 : 1096 103.
25. Nappi S, Saha H, Virtanen V, Mustonen J, Pasternack A. Hemodialysis with high-calcium dialysate impairs cardiac relaxation. Kidney Int. 1999 55 : 1091 6.
26. Ritz E, Passlick-Deetjen J, Lippert J. What is the appropriate dialysate calcium concentration for the dialysis patient? Nephrol. Dial. Transplant. 1996 11 (Suppl. 3 91 5.
27. Hutchison A, Whitehouse R, Boulton H et al. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int. 1993 44 : 1071 7.
28. Goldsmith D, Ritz E, Covic A. Vascular calcification: A stiff challenge for the nephrologist. Does preventing bone disease cause arterial disease? Kidney Int. 2004 66 : 1315 33.
29. Cozzolino M, Brancaccio D, Gallieni M, Slatopolsky E. Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int. 2005 68 : 429 36.
30. Achinger S, Ayus J. The role of vitamin D in left ventricular hypertrophy and cardiac function. Kidney Int. 2005 67 (Suppl. 95 S37 42.
31. Levin A, Li Y. Vitamin D and its analogues: Do they protect against cardiovascular disease in patients with kidney disease? Kidney Int. 2005 68 : 1973 81.
32. Teng M, Wolf M, Ofsthun N et al. Activated injectable vitamin D and haemodialysis survival: A historical cohort study. J. Am. Soc. Nephrol. 2005 16 : 1115 25.
33. Roe S, Cassidy M. Diagnosis and monitoring of renal osteodystrophy. Curr. Opin. Nephrol. Hypertens. 2000 9 : 675 81.
34. Moe S, Byunghee O, Sprague S. Maintenance of bone mass in patients receiving dialytic therapy. Am. J. Kidney Dis. 1993 22 : 300 307.
35. Jamal S, Chase C, Goh Y, Richardson R, Hawker G. Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures. Am. J. Kidney Dis. 2002 39 : 8343 9.
36. Lugon JR, Andre MB, Duarte ME, Rembold SM, Cruz E. Effects of in-center daily hemodialysis upon mineral metabolism and bone disease in end-stage renal disease patients. Sao Paulo Med. J. 2001 199 : 105 9.
37. Pierratos A, Hercz G, Sherrard D, Copland M, Ouwendyk M. Calcium, phosphorus metabolism and bone pathology on long term nocturnal hemodialysis. J. Am. Soc. Nephrol. 2001 12 : 274A.
38. Bardin T. Musculoskeletal manifestations of chronic renal failure. Curr. Opin. Rheumatol. 2003 15 : 48 54.